LIN-N 2.56 CP-T 0.22 AZN-N 0.88 MCY-N -0.66 SBS-N 0.15 AEM-T 0.11 PPL-T 0.07
Salona Global Medical (SGMD-X)

Salona Global Medical (SGMD-X)

44 watching

CVE:SGMD

0.22
0.01 (2.33%) 1d
Jan 12, 2024, 8:50 pm
0

Related posts

Nervous markets await Nvidia
PAST TOP PICK

Salona Global Medical(SGMD-X)

Sep 13, 2023
(A Top Pick Jul 04/22, Down 79%)

Achieved desired revenue base and starting to cross-sell products. New management focus on profitability, and technology should help. Amazing value right now.

Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.180

Stock price when the opinion was issued

Healthcare
BUY

Salona Global Medical(SGMD-X)

Jan 19, 2023
Underlying business still working fantastically. Comes down to market size and market cap. Trades at around 1x sales, whereas peers are around 3x sales. As they continue to grow organically and by acquisition, revenue keeps going up. Announced NASDAQ listing, which will boost multiple. Acquisition in progress should boost revenue by 35-40%, share price should move up.
Bruce Campbell (2)Bruce Campbell (2)
Unknown
Unlock Rating
$0.470

Stock price when the opinion was issued

Healthcare
TOP PICK

Salona Global Medical(SGMD-X)

Nov 21, 2022
It is in the recovery science market related to physiotherapy with machines to help patients recover from injury or surgery. It was formed one and a half years ago with 15 million in revenue growing to 50 million now, Could be 80 million by year end. Also it is profitable. The founder has successfully built out a company in a similar space and taken it from 150 million to 1.5 billion in six years then sold it to a private equity firm. Buy 2, Hold 0, Sell 0.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.590

Stock price when the opinion was issued

Healthcare
BUY

Salona Global Medical(SGMD-X)

Oct 21, 2022

Has owned stock in the company before. Company executing well and is well managed. Founder is experienced in business. Expecting revenue to grow. Margins growing fast.

Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.540

Stock price when the opinion was issued

Healthcare
BUY

Salona Global Medical(SGMD-X)

Sep 27, 2022
A headwind is that it's a small-cap which the market is not buying now. Management team has a great track record. From June 2021, they've grown the company from $10 million of annual run rate revenue to $90 million (after some acquisitions). More acquisitions and organic growth lie ahead. They're profitable. It's his largest position. He sees shares going much higher.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.620

Stock price when the opinion was issued

Healthcare
TOP PICK

Salona Global Medical(SGMD-X)

Aug 22, 2022
Has also been a past pick. When it went public just over a year ago it had $16 million in revenue which should become $70 million by year end with acquisitions and 30% organic growth. Will apply to NASDAQ when it gets to $100 revenue next year. The chairman was in the same business with DJ global which over 6 years gained 10 times. There is lots of runway to buy a business and increase cash flow. Therefore no short-term need for capital raises. Trades at 1X revenue. Buy 2 Hold 0 Sell 0 (Analysts’ price target is $2.50)
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.750

Stock price when the opinion was issued

Healthcare
TOP PICK

Salona Global Medical(SGMD-X)

Jul 04, 2022
Its IPO was just over a year ago. Its CEO built up another company and sold it for a ten-fold gain. He is doing the same thing through organic growth and acquisitions. It is trading at 1X revenue but is growing fast so should be 5 to 8X revenue. It is one of his bigger positions. In 2 to 5 years it should hit the radar screen of investors and will probably be sold when it reaches a certain size. Buy 2 Hold 0 Sell 0 (Analysts’ price target is $2.50)
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.800

Stock price when the opinion was issued

Healthcare
PAST TOP PICK

Salona Global Medical(SGMD-X)

Jun 01, 2022
(A Top Pick Jun 29/21, Down 32%) Revenues jumped 100%, earnings up 140%. CEO delivered. Pullback is surprising. Valuation is much better now.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.750

Stock price when the opinion was issued

Healthcare
TOP PICK

Salona Global Medical(SGMD-X)

Apr 22, 2022

Believes management team is excellent. Company growing organically with a mix of M&A. Trading at 1.2x sales (peers trade at 4-8x sales). Expecting share price to rise significantly.

Bruce Campbell (2)Bruce Campbell (2)
Unknown
Unlock Rating
$0.930

Stock price when the opinion was issued

Healthcare
BUY

Salona Global Medical(SGMD-X)

Feb 23, 2022
Non-hospital surgical and rehab equipment. Will grow both organically and by acquisition. Acquisitions have been delayed. Hit estimated revenue number, and this should continue. Obtained financing. Pipeline of deals. Earnings will be lumpy. Likes management. If it weren't too small, he'd make it a Top Pick.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
$0.570

Stock price when the opinion was issued

Healthcare
BUY

Salona Global Medical(SGMD-X)

Sep 02, 2021
Continue to execute. Waiting for them to integrate acquisitions. Tremendous respect for the Chairman, as he's very picky on acquisitions. Bodes well for long-term success. As they grow market cap and show up on investors' radar, stock should close valuation gap with peers.
Bruce Campbell (2)Bruce Campbell (2)
Unknown
Unlock Rating
N/A

Stock price when the opinion was issued

Healthcare
TOP PICK

Salona Global Medical(SGMD-X)

Jun 29, 2021
No price target A new company. The CEO comes from an orthotics company that he grew from $100 million to $600 million over six years until he sold it. Non-surgical devices have IP protection. They make small acquisitions and are talking to 50 small companies before they close these deals. He expects $55 revenues, but bigger deals will push that to $75-80 million. Trades at 1.2x revenues vs. peers' 4.5x-18x. Will grow by acquisition and organically as they expand into Europe.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
N/A

Stock price when the opinion was issued

Healthcare
Showing 1 to 12 of 12 entries
  • «
  • ‹
  • 1
  • ›
  • »

Salona Global Medical(SGMD-X) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Salona Global Medical is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Salona Global Medical(SGMD-X) Frequently Asked Questions

What is Salona Global Medical stock symbol?

Salona Global Medical is a Canadian stock, trading under the symbol SGMD-X on the TSX Venture Exchange (SGMD-CV). It is usually referred to as TSXV:SGMD or SGMD-X

Is Salona Global Medical a buy or a sell?

In the last year, there was no coverage of Salona Global Medical published on Stockchase.

Is Salona Global Medical a good investment or a top pick?

Salona Global Medical was recommended as a Top Pick by on . Read the latest stock experts ratings for Salona Global Medical.

Why is Salona Global Medical stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Salona Global Medical worth watching?

0 stock analysts on Stockchase covered Salona Global Medical In the last year. It is a trending stock that is worth watching.

What is Salona Global Medical stock price?

On 2024-01-12, Salona Global Medical (SGMD-X) stock closed at a price of $0.22.

Build our watch list

Sign in to track investments
you care about

Latest Buy Signals

ZM-Q -1.31$83.31
ITT-N 0.41$153.31
CVNA-N 5.32$305.21
MCD-N 2.62$321.23
GS-N -6.73$612.3

Today's Top Picks

LIN-N 2.56$460.33
CP-T 0.22$114
AZN-N 0.88$69.69
MCY-N -0.66$61.11
SBS-N 0.15$20.67

Popular Articles

Latest Sell Signals

VNOM-Q -0.08$41.28
CSGP-Q -0.08$76.91
SEZL-Q 4.965$98.75
NFLX-Q 0.11$1191.64
UNH-N 23.98$315.89

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Darren Sissons

Darren Sissons

Campbell Lee & Ross

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica